Get the Stockscreener App
0.23
20.69%
-0.06
BOTANIX PHARMACEUTICALS Stock (BXPHF) Forecast
The BOTANIX PHARMACEUTICALS (BXPHF) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.3931, representing a +70.91% increase from the current price of $0.23. The highest analyst price target is $0.5019, and the lowest is $0.2843.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BXPHF Price Target
Average 0.5836
(+153.75% Upside)
Long-term BXPHF price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about BOTANIX PHARMACEUTICALS financial reports and earnings history, BOTANIX PHARMACEUTICALS (BXPHF) stock could reach $2.179 by 2030, $5.311 by 2040 and $8.443 by 2050. See the projected annual prices until 2050 of the BOTANIX PHARMACEUTICALS stock below:
- BOTANIX PHARMACEUTICALS (BXPHF) is expected to reach an average price of $3.4865 in 2035, with a high prediction of $3.745 and a low estimate of $1.9612. This indicates an $1,416% rise from the last recorded price of $0.23.
- BOTANIX PHARMACEUTICALS (BXPHF) stock is projected to chart a bullish course in 2040, with an average price target of $4.947, representing an $2,051% surge from its current level. The forecast ranges from a conservative $2.7882 to a sky-high $5.311.
- Our analysts predict BOTANIX PHARMACEUTICALS (BXPHF) to jump 2,686% by 2045, soaring from $3.6152 to an average price of $6.4074, potentially reaching $6.877. While $3.6152 is the low estimate, the potential upside is significant.
- BOTANIX PHARMACEUTICALS (BXPHF) stock is expected to climb by 2050, reaching an average of $7.8678, a $3,321% jump from its current level. However, a wide range of estimates exists, with high and low targets of $8.443 and $4.4421, respectively, highlighting the market's uncertainty.
BOTANIX PHARMACEUTICALS Stock (BXPHF) Year by Year Forecast
BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2024
Our forecast for BXPHF stock price in 2024 now indicates an average price target of $0.323 with a high forecast of $0.559 and a low forecast of $0.0871. The average prediction reflects an increase of +40.45% from the last recorded price of $0.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $0.3509 | $0.2843 | $0.5019 | +52.56% |
BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2025
BOTANIX PHARMACEUTICALS Stock (BXPHF) is expected to reach an average price of $0.5951 in 2025, with a high prediction of $0.883 and a low estimate of $0.3072. This indicates an +158.74% rise from the last recorded price of $0.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $0.571 | $0.3072 | $0.613 | +148.28% |
| February, 2025 | $0.383 | $0.3237 | $0.545 | +66.54% |
| March, 2025 | $0.616 | $0.3357 | $0.667 | +167.84% |
| April, 2025 | $0.3312 | $0.3631 | $0.6178 | +43.99% |
| May, 2025 | $0.6664 | $0.3642 | $0.721 | +189.74% |
| June, 2025 | $0.367 | $0.4026 | $0.6645 | +59.55% |
| July, 2025 | $0.775 | $0.3928 | $0.775 | +236.96% |
| August, 2025 | $0.4028 | $0.442 | $0.7168 | +75.11% |
| September, 2025 | $0.829 | $0.4213 | $0.829 | +260.43% |
| October, 2025 | $0.4386 | $0.4814 | $0.7671 | +90.68% |
| November, 2025 | $0.883 | $0.4498 | $0.883 | +283.91% |
| December, 2025 | $0.5209 | $0.5209 | $0.8175 | +126.47% |
BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2026
The predicted value for BOTANIX PHARMACEUTICALS (BXPHF) in 2026 is set at an average of $0.8427. Estimates vary from a peak of $1.207 to a trough of $0.4783, indicating an +266.37% surge from the present price of $0.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.937 | $0.4783 | $0.937 | +307.39% |
| February, 2026 | $0.5603 | $0.5603 | $0.8678 | +143.62% |
| March, 2026 | $0.5289 | $0.5068 | $0.551 | +129.96% |
| April, 2026 | $0.8466 | $0.8466 | $0.991 | +268.08% |
| May, 2026 | $0.5676 | $0.5353 | $0.5998 | +146.76% |
| June, 2026 | $0.8897 | $0.8897 | $1.045 | +286.81% |
| July, 2026 | $0.6015 | $0.5639 | $0.6392 | +161.53% |
| August, 2026 | $0.9327 | $0.9327 | $1.099 | +305.53% |
| September, 2026 | $0.5924 | $0.5924 | $0.6786 | +157.55% |
| October, 2026 | $0.9758 | $0.9758 | $1.153 | +324.26% |
| November, 2026 | $0.6209 | $0.6209 | $0.7181 | +169.95% |
| December, 2026 | $1.085 | $1.085 | $1.207 | +371.72% |
BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for BOTANIX PHARMACEUTICALS (BXPHF) is $1.0902, with a high forecast of $1.531 and a low forecast of $0.6494. This indicates an +374.00% increase from the last price of $0.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6494 | $0.6494 | $1.0189 | +182.35% |
| February, 2027 | $1.1317 | $1.1317 | $1.261 | +392.03% |
| March, 2027 | $0.7689 | $0.7689 | $1.062 | +234.32% |
| April, 2027 | $1.1784 | $0.6779 | $1.315 | +412.35% |
| May, 2027 | $0.8011 | $0.8011 | $1.105 | +248.30% |
| June, 2027 | $1.2707 | $0.7064 | $1.369 | +452.48% |
| July, 2027 | $0.8332 | $0.8332 | $1.2251 | +262.28% |
| August, 2027 | $1.3211 | $0.735 | $1.423 | +474.38% |
| September, 2027 | $0.8323 | $0.9153 | $1.2718 | +261.89% |
| October, 2027 | $1.3714 | $0.7635 | $1.477 | +496.27% |
| November, 2027 | $0.8681 | $0.9547 | $1.3186 | +277.45% |
| December, 2027 | $1.4218 | $0.792 | $1.531 | +518.17% |
BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2028
In 2028, BOTANIX PHARMACEUTICALS (BXPHF) is projected to reach an average price of $1.3108, with a high projection of $1.801 and a low estimate of $0.8205. This indicates an +469.89% rise from the last price of $0.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.9039 | $0.9941 | $1.3653 | +293.01% |
| February, 2028 | $1.585 | $0.8205 | $1.585 | +589.13% |
| March, 2028 | $0.9397 | $1.0336 | $1.4721 | +308.58% |
| April, 2028 | $1.639 | $0.849 | $1.639 | +612.61% |
| May, 2028 | $1.073 | $1.073 | $1.5225 | +366.53% |
| June, 2028 | $1.693 | $0.8775 | $1.693 | +636.09% |
| July, 2028 | $1.1125 | $1.1125 | $1.5729 | +383.68% |
| August, 2028 | $0.9587 | $0.9061 | $1.0113 | +316.82% |
| September, 2028 | $1.1519 | $1.1519 | $1.747 | +400.83% |
| October, 2028 | $0.9908 | $0.9346 | $1.0471 | +330.80% |
| November, 2028 | $1.4928 | $1.4928 | $1.801 | +549.02% |
| December, 2028 | $1.0772 | $0.9631 | $1.1913 | +368.35% |
BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2029
The 2029 price forecast for BOTANIX PHARMACEUTICALS Stock (BXPHF) is $1.5583 on average, with a high prediction of $2.125 and a low estimate of $0.9916. This represents an +577.52% increase from the previous price of $0.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.5358 | $1.5358 | $1.855 | +567.75% |
| February, 2029 | $0.9916 | $0.9916 | $1.2308 | +331.13% |
| March, 2029 | $1.5789 | $1.5789 | $1.909 | +586.48% |
| April, 2029 | $1.0201 | $1.0201 | $1.2702 | +343.53% |
| May, 2029 | $1.739 | $1.739 | $1.963 | +656.10% |
| June, 2029 | $1.0486 | $1.0486 | $1.622 | +355.93% |
| July, 2029 | $1.7857 | $1.7857 | $2.017 | +676.41% |
| August, 2029 | $1.0772 | $1.0772 | $1.6651 | +368.33% |
| September, 2029 | $1.8325 | $1.8325 | $2.071 | +696.72% |
| October, 2029 | $1.2513 | $1.2513 | $1.7081 | +444.04% |
| November, 2029 | $1.8792 | $1.1057 | $2.125 | +717.04% |
| December, 2029 | $1.2834 | $1.2834 | $1.7512 | +458.02% |
BOTANIX PHARMACEUTICALS Stock (BXPHF) Price Forecast for 2030
BOTANIX PHARMACEUTICALS Stock (BXPHF) is expected to reach an average price of $1.7916 in 2030, with a high forecast of $2.449 and a low forecast of $1.1342. This signifies an +678.95% surge from the last price of $0.23.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.0261 | $1.1342 | $2.179 | +780.91% |
| February, 2030 | $1.3335 | $1.4674 | $1.9259 | +479.79% |
| March, 2030 | $2.0765 | $1.1627 | $2.233 | +802.81% |
| April, 2030 | $1.3693 | $1.5068 | $1.9726 | +495.35% |
| May, 2030 | $2.1268 | $1.1912 | $2.287 | +824.70% |
| June, 2030 | $1.4051 | $1.5451 | $2.0193 | +510.91% |
| July, 2030 | $2.341 | $1.2197 | $2.341 | +917.83% |
| August, 2030 | $1.4409 | $1.5809 | $2.1772 | +526.48% |
| September, 2030 | $2.395 | $1.2483 | $2.395 | +941.30% |
| October, 2030 | $1.6252 | $1.6252 | $2.2275 | +606.59% |
| November, 2030 | $2.449 | $1.2768 | $2.449 | +964.78% |
| December, 2030 | $1.6646 | $1.6646 | $2.2779 | +623.74% |
1.97%
12.32%
Cap:
|
Volume (24h):